Viking Therapeutics' shares tanked recently after its oral drug, VK2735, spooked investors with a high discontinuation rate. However, it achieved weight loss results similar to Eli Lilly's drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback